Laryngeal cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 57: Line 57:
==Microscopic==
==Microscopic==
Features based on classification:<ref name=Ref_Sternberg4_975>{{Ref Sternberg4|975}}</ref>
Features based on classification:<ref name=Ref_Sternberg4_975>{{Ref Sternberg4|975}}</ref>
*Keratinized subtype:  
*Keratinizing subtype:  
**Keratinization & intercellular bridges through-out most of the malignant lesion
**Keratinization & intercellular bridges through-out most of the malignant lesion
*Undifferentiated type:
*Undifferentiated type:
**Non-distinct borders/syncytial pattern
**Non-distinct borders/syncytial pattern
**Nucleoli
**Nucleoli
*Differentiated type:
*Non Keratinizing type:
**Well-defined cell borders
**Well-defined cell borders
**Eosinophilia
**Eosinophilia
Line 88: Line 88:
====Verrucous squamous cell carcinoma====
====Verrucous squamous cell carcinoma====
Features:
Features:
*Exophytic growth.
*Exophytic growth
*Well-differentiated.
*Well-differentiated
*"Glassy" appearance.
*"Glassy" appearance
*Pushing border.
*Pushing border


DDx: papilloma.
DDx: papilloma.


====Spindle cell squamous carcinoma====
====Spindle cell squamous carcinoma====
*Key to diagnosis is finding a component of conventional squamous cell carcinoma.
*Key to diagnosis is finding a component of conventional squamous cell carcinoma


IHC:  
IHC:  

Revision as of 14:39, 28 October 2015

Laryngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Laryngeal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal cancer pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal cancer pathophysiology

CDC on Laryngeal cancer pathophysiology

Laryngeal cancer pathophysiology in the news

Blogs on Laryngeal cancer pathophysiology

Directions to Hospitals Treating Laryngeal cancer

Risk calculators and risk factors for Laryngeal cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Hypopharyngeal cancer arises from squamous cells, which are cells that are normally involved in protection of aerodigestive tract. Genes involved in the pathogenesis of hypopharyngeal cancer include p16, NOTCH1, cyclin D1, and TP53. Hypopharyngeal cancer is associated with sideropenic dysphagia and Paterson Brown Kelly syndrome. On gross pathology, flattened plaques, mucosal ulceration, and raised margins of the lesion are characteristic findings of hypopharyngeal cancer. On microscopic histopathological analysis, spindle cells, basaloid cells, and nuclear atypia are characteristic findings of hypopharyngeal cancer.[1]

Pathophysiology

Laryngeal cancer arises from squamous cells, which are cells that are normally involved in protection of airway. Development of laryngeal cancer is the result of multiple genetic mutations. These mutations lead to activation of oncogenes and inactivation of tumor suppression genes which ultimately results in deregulated cellular proliferation.

Genetics

Genes involved in the pathogenesis of hypopharyngeal cancer include:


Gross Pathology

On gross pathology, laryngeal cancer is characterized by:

  • Flattened plaques
  • Raised margins of the lesion
  • Mucosal ulceration


Microscopic Pathology

On microscopic histopathological analysis, laryngeal carcinoma is characterized by:

Subclassification by site

It is generally divided the following way:[2]

 
 
 
 
 
 
 
 
Laryngeal cancer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supraglottis
 
 
Glottis
 
 
Subglottis

Features:[3][4]

  • Prevalence - glottis > supraglottis > subglottis.
  • Glottic carcinoma tends to present earlier (as it affects phonation) and, therefore, has a better prognosis.

SCC is subdivided by the WHO into:[5]

  • Keratinizing type (KT).
    • Worst prognosis.
  • Undifferentiated type (UT).
    • Intermediate prognosis.
    • EBV association.
  • Nonkeratinizing type (NT).
    • Good prognosis.
    • EBV association.

Microscopic

Features based on classification:[5]

  • Keratinizing subtype:
    • Keratinization & intercellular bridges through-out most of the malignant lesion
  • Undifferentiated type:
    • Non-distinct borders/syncytial pattern
    • Nucleoli
  • Non Keratinizing type:
    • Well-defined cell borders
    • Eosinophilia
    • Extra large nuclei/bizarre nuclei
    • Inflammation (lymphocytes, plasma cells)
    • Long rete ridges
    • Numerous beeds/blobs of epithelial cells that seem unlikely to be rete ridges

Images

Overview of subtypes

There are several subtypes:[7]

  • Basaloid
  • Warty (Condylomatous)
  • Verrucous
  • Papillary
  • Lymphoepithelial
  • Spindle cell

Verrucous squamous cell carcinoma

Features:

  • Exophytic growth
  • Well-differentiated
  • "Glassy" appearance
  • Pushing border

DDx: papilloma.

Spindle cell squamous carcinoma

  • Key to diagnosis is finding a component of conventional squamous cell carcinoma

IHC:

  • Typically keratin -ve.
  • p63 +ve.

DDx:

  • Spindle cell melanoma.
  • Mesenchymal neoplasm.

Basaloid squamous cell carcinoma

Features:

  • Need keratinization. (???)

DDx:

  • Neuroendocrine tumour.

Lymphoepithelial (squamous cell) carcinoma

See nasopharyngeal carcinoma.

IHC

References

  1. Helliwell TR (2003). "acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx". J Clin Pathol. 56 (2): 81–5. PMC 1769882. PMID 12560383.
  2. URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Larynx_11protocol.pdf. Accessed on: 2 May 2012.
  3. Template:Ref WMSP
  4. URL: http://www.health.am/cr/more/statistics-and-prognosis-for-cancer-of-the-larynx/. Accessed on: 2 May 2012.
  5. 5.0 5.1 Template:Ref Sternberg4
  6. 6.0 6.1 6.2 Head and neck SCC Librepathology. http://librepathology.org/wiki/index.php/Squamous_cell_carcinoma_of_the_head_and_neck Accessed on October 26, 2015
  7. URL: http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970297-2. Accessed on: March 9, 2010.
  8. URL: http://www.biomedcentral.com/1471-2407/6/146. Accessed on: March 9, 2010.
  9. Nichols AC, Finkelstein DM, Faquin WC; et al. (2010). "Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer". Clin. Cancer Res. 16 (7): 2138–46. doi:10.1158/1078-0432.CCR-09-3185. PMID 20233885. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources